Investment Details
Investor Type
Venture Capital
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Portugal, Sweden, Belgium, Greece, Norway, Finland, Poland, Czech Republic
Industries Focus
- Healthcare
- Artificial Intelligence
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Machine Learning
- Biotechnology
- Oncology
- Neurology
- Cardiology
- Endocrinology
- Immunology
- Genomics
- Orthopedics
Investment Size:
500,000 to 5,000,000 USD
Investor Details Founded: 2022
Kerna Ventures is a London-based venture capital firm established in 2022. The firm specializes in early-stage investments in advanced therapeutic platform technologies, focusing on areas such as genome engineering, cell reprogramming, and computational biology. Kerna Ventures primarily invests in seed through Series A stages, with ticket sizes ranging from $500,000 to $5 million. The firm's portfolio includes companies like GenEdit, Axent, Nodal Therapeutics, Renewal Bio, Geneditor, Pasqal, and Proteinea. Kerna Ventures is committed to supporting innovative startups that aim to revolutionize healthcare through cutting-edge scientific advancements.
Requirements
- Innovative technology startups
- Advanced therapeutic platform technologies
- Seed through Series A stages
- Ticket sizes between $500,000 and $5 million
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- GenEdit
- Axent
- Nodal Therapeutics
- Renewal Bio
- Geneditor
- PASQAL
- Proteinea
Mentioned In
-
$49.95
-
$19.95
-
$19.95
-
$39.95
-
$24.95
-
$19.95
-
$19.95
-
$24.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of Kerna Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim